pocketful logo light
pocketful logo light
Star Health & Allied Insurance Company Ltd logo

Star Health & Allied Insurance Company Ltd

NSE: STARHEALTH BSE: 543412

₹529

(1.46%)

Wed, 17 Jun 2026, 04:13 am

Star Health & Allied Insurance Company Ratios

Particulars201620172018201920202021202220232024
Price to earnings ratio00000049.8138.2832.80
Price to book ratio000006.424.594.802.98
Price to sales ratio000003.742.552.311.31
Price to cash flow ratio00000137025.6525.4915.84
Enterprise value0000040373Cr31282Cr32814Cr21656Cr
Enterprise value to EBITDA ratio---------
Debt to equity ratio00.240.180.130.060.110.070.070.07
Return on equity %016.5210.5915.98-37.01-19.659.5612.819.46

Star Health & Allied Insurance Company Ltd Ratios

The Star Health & Allied Insurance Company Ltd Ratios page provides a complete fundamental analysis of Star Health & Allied Insurance Company Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Star Health & Allied Insurance Company Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Star Health & Allied Insurance Company Ltd (NSE: STARHEALTH, BSE: 543412) is currently trading at ₹529, with a market capitalization of ₹30482.24Cr. As a major player in the Finance sector and Life/Health insurance industry, Star Health & Allied Insurance Company Ltd remains a key stock for fundamental analysis using Star Health & Allied Insurance Company Ltd Ratios.

Star Health & Allied Insurance Company Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Star Health & Allied Insurance Company Ltd P/E ratio currently stands at 32.80, making it one of the most tracked metrics in Star Health & Allied Insurance Company Ltd Ratios.

Historically, the Star Health & Allied Insurance Company Ltd P/E ratio has shown strong fluctuations:

  • 2024: 32.80
  • 2023: 38.28
  • 2022: 49.81
  • 2021: 0
  • 2020: 0

The decline in Star Health & Allied Insurance Company Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Star Health & Allied Insurance Company Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.98.

Historical P/B trend:

  • 2024: 2.98
  • 2023: 4.80
  • 2022: 4.59
  • 2021: 6.42

Star Health & Allied Insurance Company Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Star Health & Allied Insurance Company Ltd P/S ratio currently stands at 1.31, an important part of Star Health & Allied Insurance Company Ltd Ratios for revenue valuation.

Historical P/S ratio:

  • 2024: 1.31
  • 2023: 2.31
  • 2022: 2.55
  • 2021: 3.74

A stable or declining Star Health & Allied Insurance Company Ltd P/S ratio indicates cautious market sentiment.

Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio (P/CF)

The Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 15.84.

Historical Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio:

  • 2024: 15.84
  • 2023: 25.49
  • 2022: 25.65
  • 2021: 1370
  • 2020: 0

The declining Star Health & Allied Insurance Company Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Star Health & Allied Insurance Company Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Star Health & Allied Insurance Company Ltd EV currently stands at ₹21656Cr, representing the total company valuation including debt.

Historical EV trend:

  • 2024: 21656Cr
  • 2023: 32814Cr
  • 2022: 31282Cr
  • 2021: 40373Cr

Star Health & Allied Insurance Company Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Star Health & Allied Insurance Company Ltd EV/EBITDA ratio is currently 0, a key metric in Star Health & Allied Insurance Company Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

    Stable Star Health & Allied Insurance Company Ltd EV/EBITDA indicates balanced valuation.

    Star Health & Allied Insurance Company Ltd Financial Strength Ratios

    Debt to Equity Ratio (D/E)

    The Star Health & Allied Insurance Company Ltd D/E ratio is currently 0.07, reflecting leverage and financial stability.

    Historical D/E:

    • 2024: 0.07
    • 2023: 0.07
    • 2022: 0.07
    • 2021: 0.11

    Star Health & Allied Insurance Company Ltd maintains a strong balance sheet with low debt levels.

    Return on Equity (ROE %)

    The Star Health & Allied Insurance Company Ltd ROE currently stands at 9.46%, showing profitability and capital efficiency.

    Historical ROE:

    • 2024: 9.46
    • 2023: 12.81
    • 2022: 9.56
    • 2021: -19.65

    Declining ROE indicates pressure on profitability.

    Star Health & Allied Insurance Company Ltd Ratios Analysis Summary

    The Star Health & Allied Insurance Company Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Star Health & Allied Insurance Company Ltd stock is undervalued, fairly valued, or overvalued.

    Tracking Star Health & Allied Insurance Company Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.

    Open Your Free Demat Account

    Enter your phone number